SLNO R&D Expenses
Soleno Therapeutics Inc · R&D Expenses
SLNO R&D Expenses
Latest reported$38.38Mperiod ending
SLNO TTM R&D Expenses ($2.38M → $38.38M)
TTM R&D Expenses
High-resolution chart · PNG
SLNO r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 38,384,000 | |
| 40,627,000 | |
| 52,555,000 | |
| 74,288,000 | |
| 77,483,000 | |
| 78,568,000 | |
| 65,771,000 | |
| 41,676,000 | |
| 34,475,000 | |
| 25,189,000 | |
| 20,310,000 | |
| 18,038,000 | |
| 16,593,000 | |
| 15,265,000 | |
| 15,189,000 | |
| 16,386,000 | |
| 18,277,000 | |
| 21,453,000 | |
| 23,285,000 | |
| 23,144,000 | |
| 23,660,000 | |
| 23,191,000 | |
| 22,897,000 | |
| 22,560,000 | |
| 20,202,000 | |
| 16,267,000 | |
| 13,187,000 | |
| 10,789,000 | |
| 8,758,000 | |
| 7,178,000 | |
| 6,008,742 | |
| 4,898,742 | |
| 4,158,742 | |
| 3,972,742 | |
| 3,903,803 | |
| 4,052,803 | |
| 4,405,803 | |
| 5,183,803 | |
| 5,514,244 | |
| 5,576,244 | |
| 5,430,244 | |
| 4,536,244 | |
| 3,861,216 | |
| 3,385,216 | |
| 2,753,216 | |
| 2,247,270 | |
| 1,997,886 | |
| 2,025,886 | |
| 2,048,821 | |
| 2,379,687 |